12
PHAM ET AL.
1
0. Yang W, Wang Y, Ma Z, et al. Synthesis and structure-activity
relationship of 3-arylbenzoxazines as selective estrogen
alcohols and chiral benzoxazine/quinoxaline derivatives. Org
Lett. 2015;17(18):4576-4579.
receptor
β
agonists. Bioorg Med Chem Lett. 2004;14(9):
26. Liu ZT, Wang YH, Zhu FL, Hu XP. Enantioselective copper-
catalyzed formal [4+2] cycloaddition of o-aminophenol
derivatives with propargylic esters for synthesis of optically
active 3,4-dihydro-2H-1,4-benzoxazines. Org Lett. 2016;18(5):
1190-1193.
2
327-2330.
1
1. Touzeau F, Arrault A, Guillaumet G, et al. Synthesis and bio-
logical evaluation of new 2-(4,5-dihydro-1H-imidazol-2-yl)-
3
,4-dihydro-2H-1,4-benzoxazine derivatives. J Med Chem. 2003;
4
6(10):1962-1979.
27. Shen HC, Wu YF, Zhang Y, Fan LF, Han ZY, Gong LZ. Palla-
dium-catalyzed asymmetric aminohydroxylation of 1,3-Dienes.
Angew Chem Int Ed. 2018;57(9):2372-2376.
1
1
1
1
1
1
2. La DS, Belzile J, Bready JV, et al. Novel 2,3-dihydro-
1
,4-benzoxazines as potent and orally bioavailable inhibitors of
tumor-driven angiogenesis. J Med Chem. 2008;51(6):1695-1705.
3. Honda T, Terao T, Aono H, Ban M. Synthesis of novel
28. Pawliczek M, Shimazaki Y. Phase-transfer-catalysed asymmet-
ric synthesis of 2,2-disubstituted 1,4-benzoxazin-3-ones. Chem
Commun. 2016;52(1):64-67.
1
,4-benzoxazin-3-one derivatives as inhibitors against tyrosine
kinases. Bioorg Med Chem. 2009;17(2):699-708.
29. Breznik M, Hrast V, Mrcina A, Kikelj D. Stereoselective
synthesis of (R)- and (S)-2-methyl-3-oxo-3,4-dihydro-2H-
1,4-benzoxazine-2-carboxylic acids, -carboxylates and -carbox-
amides. Tetrahedron Asymmetry. 1999;10(1):153-167.
30. L ꢀo pez-Iglesias M, Busto E, Gotor V, Gotor-Fern ꢀa ndez V.
Chemoenzymatic asymmetric synthesis of 1,4-benzoxazine
derivatives: application in the synthesis of a Levofloxacin pre-
cursor. J Org Chem. 2015;80(8):3815-3824.
31. Charushin VN, Krasnov VP, Levit GL, et al. Kinetic resolution
of (±)-2,3-dihydro-3-methyl-4H-1,4-benzoxazines with (S)-
Naproxen. Tetrahedron Asymmetry. 1999;10(14):2691-2702.
32. Slepukhin PA, Gruzdev DA, Chulakov EN, Levit GL,
Krasnov VP, Charushin VN. Structures of the racemate and
(S)-enantiomer of 7,8-difluoro-3-methyl-2,3-dihydro-4H-[1,4]
benzoxazine. Russ Chem Bull. 2011;60(5):955-960.
33. Vakarov SA, Gruzdev DА, Sadretdinova LS, et al. Mutual
kinetic resolution of 3-methyl-3,4-dihydro-2H-1,4-benzoxazines
and 2-alkoxyacyl chlorides. Chem Heterocycl Compd. 2018;
54(4):437-446.
34. Jung EK, Pilkington LI, Barker D. Enantioselective synthesis of
2,3-disubstituted benzomorpholines: analogues of lignan natu-
ral products. J Org Chem. 2016;81(23):12012-12022.
35. Kang SB, Ahn EJ, Kim YA. Facile synthesis of (S)-(À)-7,-
8-difluoro-3,4-dihydro-3-methyl-2H-1,4-benzoxazine by zinc
chloride assisted Mitsunobu cyclization reaction. Tetrahedron
Lett. 1996;37(52):9317-9320.
36. Bower JF, Szeto P, Gallagher T. Enantiopure 1,4-benzoxazines
via 1,2-cyclic sulfamidates. Synthesis of levofloxacin. Org Lett.
2007;9(17):3283-3286.
37. Mayer S, Arrault A, Guillaumet G, Mérour JY. Attempted syn-
thesis of ethyl 3,4-dihydro-2H-1,4-benzoxazine-3-carboxylate
and 3-acetate derivatives. J Heterocyclic Chem. 2001;38(1):
221-225.
4. Ili ꢀc M, Ilaš J, Dunkel P, et al. Novel 1,4-benzoxazine and
1,4-benzodioxine inhibitors of angiogenesis. Eur J Med Chem.
2
012;58:160-170.
5. Ili ꢀc M, Kikelj D, Ilaš J. Fluorinated dual antithrombotic com-
pounds based on 1,4-benzoxazine scaffold. Eur J Med Chem.
2
012;50:255-263.
6. Ilaš J, Tomaši ꢀc T, Kikelj D. Novel potent and selective throm-
bin inhibitors based on a central 1,4-benzoxazin-3(4H)-one
scaffold. J Med Chem. 2008;51(9):2863-2867.
7. Blattes E, Lockhart B, Lestage P, et al. Novel 2-alkylamino-1,-
4
-benzoxazine derivatives as potent neuroprotective agents:
structureÀactivity relationship studies. J Med Chem. 2005;
8(4):1282-1286.
8. Wang L, Ankati H, Akubathini SK, et al. Identification of novel
,4-benzoxazine compounds that are protective in tissue cul-
ture and in vivo models of neurodegeneration. J Neurosci Res.
010;88(9):1970-1984.
4
1
1
1
2
9. Campos Rosa JM, García Rubiño ME, Marchal Corrales JA,
Morata Tarifa C, Ramírez Rivera A, Paz RA. Preparation of six-
membered benzo-heterocycles having oxygen and nitrogen
atoms with anti-tumor activity. PCT Int Appl. 2017.
WO2017064350 A1 20170420
2
2
2
1
0. Rook JM, Bertron JL, Cho HP, et al. A novel M PAM
VU0486846 exerts efficacy in cognition models without dis-
playing agonist activity or cholinergic toxicity. ACS Chem
Nerosci. 2018;9(9):2274-2285.
1. Zhang G, Ren B, Wang H, et al. 5-Amino-4-carbamoyl-pyrazole
compounds as selective and irreversible T790M over WT-EGFR
kinase inhibitors and their preparation. PCT Int Appl. 2016.
WO2016008411 A1 20160121
2. Ilaš J, Anderluh PŠ, Dolenc MS, Kikelj D. Recent advances
in the synthesis of 2H-1,4-benzoxazin-3-(4H)-ones and
3
7
,4-dihydro-2H-1,4-benzoxazines. Tetrahedron. 2005;61(31):
325-7348.
38. Mayer S, Guillaumet G, Mérour JY. Regioselective formylation
of ethyl 3,4-dihydro-2H-1,4-benzoxazine-2-carboxylate or
2-acetate derivatives. Heterocycles. 2001;55(10):1873-1888.
39. Štefani cˇ P, Turnšek K, Kikelj D. Synthesis of alkyl 4-alkyl-
2-hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-
2
2
3. Gao K, Yu CB, Wang DS, Zhou YG. Iridium-catalyzed asym-
metric hydrogenation of 3-substituted 2H-1,4-benzoxazines.
Adv Synth Catal. 2012;354(2-3):483-488.
4. Fleischer S, Zhou S, Werkmeister S, Junge K, Beller M. Cooper-
ative iron-brønsted acid catalysis: enantioselective hydrogena-
tion of quinoxalines and 2H-1,4-benzoxazines. Chem A Eur J.
2-carboxylates as peptidomimetic building blocks. Tetrahedron.
2003;59(36):7123-7129.
40. Zhou D, Harrison BL, Shah U, et al. Studies toward the discov-
ery of the next generation of antidepressants. Part 5:
3,4-Dihydro-2H-benzo[1,4]oxazine derivatives with dual
5-HT1A receptor and serotonin transporter affinity. Bioorg Med
2
013;19(16):4997-5003.
2
5. Srikanth G, Ramakrishna KVS, Sharma GVM. A double activa-
tion method for the conversion of vinyl epoxides into vic-amino